Correlation between C-reactive protein, intravenous hydrocortisone, systemic tranexamic acid and post mastectomy seroma


  • Ayman A. Albatanony General Surgery Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt
  • Ahmed M. A. Assar Police Hospital Nasr City, Cairo, Egypt
  • Mohammed A. E. El Balshy General Surgery Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt



CRP, Hydrocortisone, Mastectomy, Seroma, Tranexamic acid


Background: Breast cancer is the second leading cause of death among women worldwide. Formation of a seroma most frequently occurs after mastectomy and axillary surgery. The objective was to find the correlation between the formation of post modified radical mastectomy seroma and C-reactive protein (CRP) and the effect of preoperative intravenous (IV) hydrocortisone, systemic tranexamic acid.

Methods: This prospective study was conducted at Menoufia university hospital on female patients with primary operable breast cancer who were divided to two groups; each included 30 patients: group I received general anesthesia with hydrocortisone therapy (Solu-Cortef 100 mg solution once), systemic tranexamic acid (kapron 5 ml once) and group II received general anesthesia without hydrocortisone nor tranexamic acid. CRP serum levels before surgery and 24 hour after the procedure. All patients were followed up postoperatively for registration of the total drainage volume until drain removal, timing of drain removal, incidence of seroma formation and management of seroma.

Results: Our results revealed that a significant difference between both groups as regard CRP, the incidence of seroma, time of removing the drain and total collection of the drain in favor to those who received IV hydrocortisone and systemic tranexamic acid.

Conclusions: Induction of IV hydrocortisone, systemic tranexamic acid with general anaesthesia during modified radical mastectomy (MRM) are significantly decreasing the level of CRP, the incidence of seroma, time of removing the drain and total collection of the drain.


Abass MO, Gismalla MDA, Alsheikh AA, Elhassan MMA. Axillary lymph node dissection for breast cancer: efficacy and complication in developing countries. J Glob Oncol. 2018;4:1-8.

Srivastava V, Basu S, Shukla VK. Seroma formation after breast cancer surgery: what we have learned in the last two decades. J Breast Cancer. 2012;15(4):373-80.

Suresh BP, Sachin HG, Naidu M, Gopalkrishna V. A study to evaluate the factors influencing seroma formation after breast cancer surgery at tertiary care centre. Int Surg J. 2018;6(1):278-82.

Khan MA. Effect of preoperative intravenous steriods on seroma formation after modified radical mastectomy. J Ayub Med Coll Abbottabad. 2017;29(2):207-10.

Szecsi BP, Larsen J, Horby J, Axelsson CK. Seroma production after breast cancer surgery has a pro-inflammatory component. Open Breast Cancer J. 2012;4(1):11-7.

Suh YC, Oh TM, Lee YH, Kim EK, Han HH, Eom JS. Effects of hydrochlorothiazide on drainage volume and seroma formation in deep inferior epigastric perforator flap breast reconstruction: Randomized controlled trial. J Plast Reconstr Aesthet Surg. 2020;73(4):663-72.

Talha A, Ramadan R, Abdelhamid S, Hamdi S. Postmastectomy seroma: how much is it affected by serum levels of IL-6 and CRP and how much is it reduced by intravenous hydrocortisone injection?. Egypt J Surg. 2015;34(1):17-21.

Douay N, Akerman G, Clement D, Malartic C, Morel O, Barranger E. Seroma after axillary lymph node dissection in breast cancer. Gynecologie Obstetrique Fertilite. 2008;36(2):130-5.

Eldesouky MS, Ashour HS, Shahin MA. Effect of topical application of tranexamic acid on reduction of wound drainage and seroma formation after mastectomy. Egypt J Surg. 2019;38(4):772.

Qvamme G, Axelsson CK, Lanng C, Mortensen M, Wegeberg B, Okholm M, et al. Randomized clinical trial of prevention of seroma formation after mastectomy by local methylprednisolone injection. Brit J Surg. 2015;102(10):1195-203.

Shyamsundar R. A study on local injection of methylprednisolone acetate to prevent seroma formation after mastectomy. Madras Med Coll. 2020.

Hashemi E, Kaviani A, Najafi M, Ebrahimi M, Hooshmand H, Montazeri A. Seroma formation after surgery for breast cancer. World J Surg Oncol. 2004;2(1):1-5.

Andersson VJ. Seroma formation following breast surgery-incidence and risk factors. Örebro Univ Sch Med. 2016.

Pan XF, Huan JL, Qin XJ. Potential risk factors for the development of seroma following mastectomy with axillary dissection. Mol Clinic Oncol. 2015;3(1):222-6.

Knight H, Banks J, Muchmore J, Ives C, Green M. Examining the use of intraoperative tranexamic acid in oncoplastic breast surgery. Breast J. 2019;25(5):1047-9.

Ravishankaran P, Karunanithi R. Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients. World J Surg Oncol. 2011;9(1):1-6.

Kozomara D, Galić G, Brekalo Z, Šutalo N, Kvesić A, Šoljić M. A randomised two-way comparison of mastectomy performed using harmonic scalpel or monopolar diathermy. Collegium Antropologicum. 2010;34(1):105-12.

O’Riain SC, Buggy DJ, Kerin MJ, Watson RW, Moriarty DC. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg. 2005;100(1):244-9.

Uslukaya Ö, Türkoğlu A, Gümüş M, Bozdağ Z, Yılmaz A, Gümüş H, et al. Factors that affect drain indwelling time after breast cancer surgery. J Breast Health. 2016;12(3):102.

Barwell J, Campbell L, Watkins RM, Teasdale C. How long should suction drains stay in after breast surgery with axillary dissection?. Ann Royal Coll Surg England. 1997;79(6):435.

Andeweg CS, Schriek MJ, Heisterkamp J, Roukema JA. Seroma formation in two cohorts after axillary lymph node dissection in breast cancer surgery: does timing of drain removal matter? Breast J. 2011;17(4):359-64.

Taylor JC, Rai S, Hoar F, Brown H, Vishwanath L. Breast cancer surgery without suction drainage: the impact of adopting a ‘no drains’ policy on symptomatic seroma formation rates. European J Surg Oncol (EJSO). 2013;39(4):334-8.






Original Research Articles